The shares of Bharti Airtel Limited took a hit of around 2 per cent as the company was issued a demand notice, charging penalties worth Rs. 11 lakh for the quarter ending March 2018. 

Sun Pharma’s Mohali plant in Punjab is undergoing a three-day surprise investigation by the USFDA. The investigation commenced on September 10, 2018, confirmed the company in an exchange filing. The company is of the opinion that the investigation will not cause any material impact.

Cipla’s first-line triple-combination treatment for HIV receives approval from the South African Health Products Regulatory Authority (SAHPRA). The newly developed combination drug will be produced locally for the African market.

Narayana Hrudayalaya’s step-down subsidiary, NH Health Bangladesh, has entered into definitive agreements to partner with Imperial Hospital in Chittagong, Bangladesh to operate and manage their cardiac sciences department.

Big data analytics along with Artificial Intelligence is changing the face of every industry it is being used in. Asset management companies are yet to implement this on a large scale.

Overall volumes in futures & options currently stand at 1.24 crore contracts with a turnover of Rs. 12,62,935.13 crore.

Overall volumes in futures & options currently stand at 1.24 crore contracts with a turnover of Rs. 12,62,935.13 crore.

The zone of 11,290-11,320 would act as a key support zone for the Nifty. Stocks in news: SITI Networks, Alembic, Wipro, CIPLA, Sun Pharmaceutical, Bharti Airtel, Reliance Industries, Godrej Agrovet and Redington.

Indian markets are expected to open flat as cues from Asian markets continue to be negative. The SGX Nifty suggests that Nifty could open up by 6 points around the level of 11,327.  

Consumption-based companies have witnessed a sharp fall in their share prices in the last one week. What should you do with funds dedicated to consumption?